Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis
Biomedicines
As revised 23 March 2023
https://www.mdpi.com/2227-9059/11/4/1087
JanOne to Present Important Trial Results at Annual Meeting of American Society of Interventional Pain Physicians
22 February 2023
https://www.biospace.com/article/releases/janone-to-present-important-trial-results-at-annual-meeting-of-american-society-of-interventional-pain-physicians/
Jenny - US: LDN, CRPS and Small Fibre Neuropathy (LDN; low dose naltrexone)
‘Promising Results’ for Low-Dose Naltrexone as Pain Reliever
Pain News Network
15 November 2022
https://www.painnewsnetwork.org/stories/2022/11/15/promising-results-for-low-dose-naltrexone-as-pain-reliever
Low-Dose Naltrexone Promising for pain relief in fibromyalgia and host of chronic conditions
Medical Dialogues
15 November 2022
https://medicaldialogues.in/medicine/news/low-dose-naltrexone-promising-for-pain-relief-in-fibromyalgia-and-host-of-chronic-conditions-102374
The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details
LDN Webinar Presentation 18 May 2022: Dr Masoud Rashidi - LDN, Dosing, Fillers and Compounded Options. LDN, ULDN and Pain/Opioid Issues
Sponsored by Innovative Compounding Pharmacy https://icpfolsom.com/